82 related articles for article (PubMed ID: 10528831)
1. Differential diagnosis of endometrial hyperplasia and carcinoma by computerized image cytometry of cell proliferation, apoptosis and Bcl-2 expression.
Mora LB; Diaz JI; Cantor AB; Nicosia SV
Ann Clin Lab Sci; 1999; 29(4):308-15. PubMed ID: 10528831
[TBL] [Abstract][Full Text] [Related]
2. Could E-Cadherin and CD10 Expression be Used to Differentiate Between Atypical Endometrial Hyperplasia and Endometrial Carcinoma?
Youssef MY; Mohamed MA
Int J Gynecol Pathol; 2019 Mar; 38(2):128-137. PubMed ID: 30726192
[TBL] [Abstract][Full Text] [Related]
3. The role of immunohistochemical adrenomedullin and Bcl-2 expression in development of type-1 endometrial adenocarcinoma: Adrenomedullin expression in endometrium.
Bozkurt KK; Yalçın Y; Erdemoğlu E; Tatar B; Erdemoğlu E; Çerçi SS; Çiriş İM; Başpınar Ş; Uğuz A; Kapucuoğlu N
Pathol Res Pract; 2016 May; 212(5):450-5. PubMed ID: 26972419
[TBL] [Abstract][Full Text] [Related]
4. Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinoma.
Liu LC; Lai HC; Chou YC; Huang RL; Yu MH; Lin CP; Tsai WC; Chiang KJ; Wang YC; Chao TK
J Obstet Gynaecol Res; 2016 Sep; 42(9):1159-67. PubMed ID: 27226215
[TBL] [Abstract][Full Text] [Related]
5. Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies.
Shawana S; Kehar SI; Masood S; Aamir I
J Coll Physicians Surg Pak; 2016 Apr; 26(4):277-82. PubMed ID: 27097697
[TBL] [Abstract][Full Text] [Related]
6. Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma.
Assaf MI; Abd El-Aal W; Mohamed SS; Yassen NN; Mohamed EA
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2291-2297. PubMed ID: 30139240
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53, Bcl-2 and Bax in endometrial carcinoma, endometrial hyperplasia and normal endometrium: a histopathological study.
Mirakhor Samani S; Ezazi Bojnordi T; Zarghampour M; Merat S; Fouladi DF
J Obstet Gynaecol; 2018 Oct; 38(7):999-1004. PubMed ID: 29560769
[TBL] [Abstract][Full Text] [Related]
8. Can Nup88 expression be associated with atypical endometrial hyperplasia and endometrial cancer? A preliminary study.
Li Y; Zhang X; Ge J; Liu X; Xu S; Zhu Z; Fang G; Liu J; Zhang H; Sun X
Pathol Res Pract; 2016 Apr; 212(4):274-8. PubMed ID: 26839161
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Study of Ki-67 in Hyperplastic and Endometrium Carcinoma: A Comparative Study.
Ghalib Farhood R; Abd Ali Al-Humairi I
Arch Razi Inst; 2022 Feb; 77(1):229-234. PubMed ID: 35891746
[TBL] [Abstract][Full Text] [Related]
10. Proliferative and apoptotic changes in the healthy canine endometrium and in cystic endometrial hyperplasia.
Reusche N; Beineke A; Urhausen C; Beyerbach M; Schmicke M; Kramer S; Günzel-Apel AR
Theriogenology; 2018 Jul; 114():14-24. PubMed ID: 29574305
[TBL] [Abstract][Full Text] [Related]
11. BCL-2 and PAX2 Expressions in EIN which Had Been Previously Diagnosed as Non-Atypical Hyperplasia.
Trabzonlu L; Muezzinoglu B; Corakci A
Pathol Oncol Res; 2019 Apr; 25(2):471-476. PubMed ID: 29270778
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis in endometrial cancer and endometrial hyperplasia tissues by 2D-DIGE technique.
Ceylan Y; Akpınar G; Doger E; Kasap M; Guzel N; Karaosmanoglu K; Kopuk SY; Yucesoy I
J Gynecol Obstet Hum Reprod; 2020 Feb; 49(2):101652. PubMed ID: 31783195
[TBL] [Abstract][Full Text] [Related]
13. Morphometric analysis of endometrial cells in liquid-based cervical cytology samples.
Gupta P; Gupta N; Dey P
Cytopathology; 2017 Apr; 28(2):140-148. PubMed ID: 27510614
[TBL] [Abstract][Full Text] [Related]
14. Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: A specific marker of precancer and novel indication for treatment: A systematic review and meta-analysis.
Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
Acta Obstet Gynecol Scand; 2018 Dec; 97(12):1415-1426. PubMed ID: 30168854
[TBL] [Abstract][Full Text] [Related]
15. Relevance of Bcl-x expression in different types of endometrial tissues.
Ma X; Zhao Y; Li Y; Lu H; He Y
J Exp Clin Cancer Res; 2010 Feb; 29(1):14. PubMed ID: 20178603
[TBL] [Abstract][Full Text] [Related]
16. Risk of atypical hyperplasia and endometrial carcinoma after initial diagnosis of non-atypical endometrial hyperplasia: A long-term follow-up study.
Prip CM; Stentebjerg M; Bennetsen MH; Petersen LK; Bor P
PLoS One; 2022; 17(4):e0266339. PubMed ID: 35413062
[TBL] [Abstract][Full Text] [Related]
17. Endometrial cytopathology. An image analysis approach using the Ki-67 biomarker.
Apostolou G; Apostolou N; Moulos P; Chatzipantelis P
Cytopathology; 2017 Oct; 28(5):385-390. PubMed ID: 28737230
[TBL] [Abstract][Full Text] [Related]
18. The role of syndecan-1 during endometrial carcinoma progression.
Solmaz OA
J Cancer Res Ther; 2019; 15(6):1265-1269. PubMed ID: 31898658
[TBL] [Abstract][Full Text] [Related]
19. Expression of Cyclin D1 in Hyperplasia and Carcinoma of Endometrium and Its Correlation with Histologic Grade, Tumor Type, and Clinicopathological Features.
Sangwan K; Garg M; Pathak N; Bharti L
J Lab Physicians; 2020 Dec; 12(3):165-170. PubMed ID: 33268933
[No Abstract] [Full Text] [Related]
20. Simultaneous FTIR and Raman Spectroscopy in Endometrial Atypical Hyperplasia and Cancer.
Barnas E; Skret-Magierlo J; Skret A; Kaznowska E; Depciuch J; Szmuc K; Łach K; Krawczyk-Marć I; Cebulski J
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]